Neurogene (NGNE) Other Non-Current Liabilities (2013 - 2026)
Neurogene (NGNE) reported Other Non-Current Liabilities of $407,000 for Q2 2026, down 44.9% from $738,000 a year earlier and down 0.5% from the prior quarter.
Powered by 
Analysis
Neurogene (NGNE) Other Non-Current Liabilities (2013 - 2026) Analysis & Trends
At the end of FY2025, Neurogene posted Other Non-Current Liabilities of $428,000, down 40.4% from FY2024.
- By year, Other Non-Current Liabilities came in at $718,000 in FY2024 (-28.6%) and $1.01 million in FY2023.
- The Q2 2026 figure ranks as the lowest quarterly Other Non-Current Liabilities since Q2 2019.
- Year over year, Other Non-Current Liabilities has now declined in each of the last four quarters, with an average decline of 29.0% over the last seven quarters.
- Per Business Quant data, the three quarters before Q2 2026 came in at $409,000 (Q1 2026), $428,000 (Q4 2025) and $427,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Neurogene | 627.40 Mn | 627.40 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 407,000.00 |
| Mar 31, 2026 | 409,000.00 |
| Dec 31, 2025 | 428,000.00 |
| Sep 30, 2025 | 427,000.00 |
| Jun 30, 2025 | 738,000.00 |
| Mar 31, 2025 | 738,000.00 |
| Dec 31, 2024 | 718,000.00 |
| Sep 30, 2024 | 646,000.00 |
| Jun 30, 2024 | 717,000.00 |
| Mar 31, 2024 | 857,000.00 |
| Dec 31, 2023 | 1.01 Mn |
| Jun 30, 2019 | 2,000.00 |
| Mar 31, 2019 | 4,000.00 |
| Dec 31, 2018 | 313,000.00 |
| Sep 30, 2018 | 343,000.00 |
| Jun 30, 2018 | 401,000.00 |
| Mar 31, 2018 | 443,000.00 |
| Dec 31, 2017 | 486,000.00 |
| Sep 30, 2017 | 513,000.00 |
| Jun 30, 2017 | 548,000.00 |
API Access
Neurogene Other Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=NGNE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-liabilities", "ticker": "NGNE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=NGNE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();